이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
ResMed 관리
관리 기준 확인 4/4
ResMed's CEO는 Mick Farrell, Mar2013 에 임명되었습니다 의 임기는 11.25 년입니다. 총 연간 보상은 $ 13.87M, 8.1% 로 구성됩니다. 8.1% 급여 및 91.9% 보너스(회사 주식 및 옵션 포함). 는 $ 94.44M 가치에 해당하는 회사 주식의 0.3% 직접 소유합니다. 94.44M. 경영진과 이사회의 평균 재임 기간은 각각 3.3 년과 8.6 년입니다.
주요 정보
Mick Farrell
최고 경영자
US$13.9m
총 보상
| CEO 급여 비율 | 8.1% |
| CEO 임기 | 11.3yrs |
| CEO 소유권 | 0.3% |
| 경영진 평균 재임 기간 | 3.3yrs |
| 이사회 평균 재임 기간 | 8.6yrs |
최근 관리 업데이트
Recent updates
ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30
Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Could Be Struggling To Allocate Capital
Apr 24Here's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investors
Apr 09A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD)
Mar 26ResMed goes ex dividend tomorrow
Feb 07ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06ResMed: The GARP Story Continues, Technicals Showing Vital Signs
Jan 26Why The 23% Return On Capital At ResMed (NYSE:RMD) Should Have Your Attention
Jan 23We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
Dec 28Calculating The Fair Value Of ResMed Inc. (NYSE:RMD)
Dec 16ResMed: Strong Earnings Growth Supports The High Valuation, Unclear Technical Trends
Nov 14CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$958m |
| Dec 31 2023 | n/a | n/a | US$890m |
| Sep 30 2023 | n/a | n/a | US$907m |
| Jun 30 2023 | US$14m | US$1m | US$898m |
| Mar 31 2023 | n/a | n/a | US$863m |
| Dec 31 2022 | n/a | n/a | US$809m |
| Sep 30 2022 | n/a | n/a | US$786m |
| Jun 30 2022 | US$12m | US$1m | US$779m |
| Mar 31 2022 | n/a | n/a | US$779m |
| Dec 31 2021 | n/a | n/a | US$522m |
| Sep 30 2021 | n/a | n/a | US$500m |
| Jun 30 2021 | US$10m | US$1m | US$475m |
| Mar 31 2021 | n/a | n/a | US$457m |
| Dec 31 2020 | n/a | n/a | US$699m |
| Sep 30 2020 | n/a | n/a | US$680m |
| Jun 30 2020 | US$10m | US$1m | US$622m |
| Mar 31 2020 | n/a | n/a | US$513m |
| Dec 31 2019 | n/a | n/a | US$455m |
| Sep 30 2019 | n/a | n/a | US$419m |
| Jun 30 2019 | US$10m | US$967k | US$405m |
| Mar 31 2019 | n/a | n/a | US$446m |
| Dec 31 2018 | n/a | n/a | US$450m |
| Sep 30 2018 | n/a | n/a | US$335m |
| Jun 30 2018 | US$9m | US$934k | US$316m |
| Mar 31 2018 | n/a | n/a | US$307m |
| Dec 31 2017 | n/a | n/a | US$285m |
| Sep 30 2017 | n/a | n/a | US$352m |
| Jun 30 2017 | US$8m | US$890k | US$342m |
보상 대 시장: Mick 의 총 보상 ($USD 13.87M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 13.50M ).
보상과 수익: Mick 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Mick Farrell (52 yo)
11.3yrs
테뉴어
US$13,868,641
보상
Mr. Michael J. Farrell, also known as Mick, BE, SM, MBA, served as Director of Fullbay, Inc. since May 2023 until 2023. He serves as Member of Advisory Board at Green Sun Medical, LLC. He serves as the Chi...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman | 11.3yrs | US$13.87m | 0.30% $ 85.2m | |
| Founder | no data | US$680.27k | 0.060% $ 16.8m | |
| Chief Financial Officer | 18.4yrs | US$3.11m | 0.062% $ 17.4m | |
| Special Advisor | less than a year | US$6.67m | 0.18% $ 50.6m | |
| Chief Commercial Officer - SaaS | 2.3yrs | US$3.31m | 0.0088% $ 2.5m | |
| Chief Investor Relations Officer | 1.2yrs | 데이터 없음 | 데이터 없음 | |
| Chief Legal Officer | less than a year | 데이터 없음 | 0.0044% $ 1.2m | |
| Chief Compliance Officer | 6.4yrs | 데이터 없음 | 데이터 없음 | |
| Chief Marketing Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief People Officer | 3.3yrs | 데이터 없음 | 데이터 없음 | |
| Chief Strategy Officer | 9.5yrs | 데이터 없음 | 데이터 없음 | |
| Chief Product Officer | 8.1yrs | 데이터 없음 | 0.045% $ 12.8m |
3.3yrs
평균 재임 기간
57yo
평균 연령
경험이 풍부한 관리: RMD 의 관리팀은 경험 ( 3.3 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman | 11.3yrs | US$13.87m | 0.30% $ 85.2m | |
| Founder | 35yrs | US$680.27k | 0.060% $ 16.8m | |
| Independent Director | 18.8yrs | US$340.06k | 0.010% $ 2.9m | |
| Lead Independent Director | 19.4yrs | US$372.56k | 0.014% $ 4.0m | |
| Independent Non-Executive Director | 5.1yrs | US$320.06k | 0.0039% $ 1.1m | |
| Independent Director | 5.6yrs | US$320.06k | 0.0049% $ 1.4m | |
| Independent Director | 10.6yrs | US$360.06k | 0.010% $ 2.9m | |
| Independent Director | 6.6yrs | US$320.06k | 0.0052% $ 1.4m | |
| Independent Director | 2.6yrs | US$320.06k | 0.0014% $ 396.8k | |
| Independent Director | 2.6yrs | US$320.06k | 0.0014% $ 396.8k |
8.6yrs
평균 재임 기간
62yo
평균 연령
경험이 풍부한 이사회: RMD 의 이사회는 경험(평균 재직 기간 8.6 년)으로 간주됩니다.